Serum Institute of India (SII) to manufacture the indigenously-developed India's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer. The Drugs Controller General of India (DCGI) approved India's first Quadri-valent Human Papillomavirus vaccine (qHPV) against cervical cancer.
RBI has decided to engage Mumbai-based Hansa Research Group to conduct fieldwork for the July 2022 round of the consumer confidence survey (CCS) and inflation expectation survey of households (IESH).
The South Indian Bank has signed an agreement with Kerala's Forest and Wildlife Department to enable digital collection of payments at eco-tourism centres, Vanasree shops, mobile Vanasree units and eco-shops across the State, of Tamil Nadu.